Deaths from Alzheimer's disease in Scotland increase by 33.4% in one year

by Alzheimer's Research UKDeaths from Alzheimer's in Scotland have soared by 33.4 percent in a year, according to new statistics released by the National Records of Scotland today.Provisi

Updated on: March 07,2024 14

Deaths from Alzheimer's disease in Scotland increase by 33.4% in one year

by Alzheimer's Research UKDeaths from Alzheimer's in Scotland have soared by 33.4 percent in a year, according to new statistics released by the National Records of Scotland today.Provisi

Updated on:March 07,2024 14

Opioid analgesics reduce use of antipsychotics in persons with Alzheimer's disease

by University of Eastern FinlandInitiating an opioid analgesic reduced the use of antipsychotics and benzodiazepines in persons with Alzheimer's disease, a recent study from the University of

Updated on: March 07,2024 12

Opioid analgesics reduce use of antipsychotics in persons with Alzheimer's disease

by University of Eastern FinlandInitiating an opioid analgesic reduced the use of antipsychotics and benzodiazepines in persons with Alzheimer's disease, a recent study from the University of

Updated on:March 07,2024 12

Using tau imaging as diagnostic marker for Alzheimer disease

by The JAMA Network JournalsThe accumulation of β-Amyloid (Αβ) and tau proteins in the brain is hallmark pathology for Alzheimer disease. Recently developed positron emission tomography (PET) tra

Updated on: March 07,2024 20

Using tau imaging as diagnostic marker for Alzheimer disease

by The JAMA Network JournalsThe accumulation of β-Amyloid (Αβ) and tau proteins in the brain is hallmark pathology for Alzheimer disease. Recently developed positron emission tomography (PET) tra

Updated on:March 07,2024 20

New figures show dementia is leading cause of death in England and Wales

by Alzheimer's Research UKNew figures released by the Office of National Statistics show that for the first time, Alzheimer's disease and other dementias are the leading cause of death fo

Updated on: March 07,2024 17

New figures show dementia is leading cause of death in England and Wales

by Alzheimer's Research UKNew figures released by the Office of National Statistics show that for the first time, Alzheimer's disease and other dementias are the leading cause of death fo

Updated on:March 07,2024 17

First U.S. clinical trial using adult allogeneic stem cells to treat Alzheimer's disease

by Emory UniversityA new study to assess the safety, tolerability and preliminary efficacy of allogeneic stem cells in persons with mild to moderate dementia due to Alzheimer's disease (AD) i

Updated on: March 07,2024 20

First U.S. clinical trial using adult allogeneic stem cells to treat Alzheimer's disease

by Emory UniversityA new study to assess the safety, tolerability and preliminary efficacy of allogeneic stem cells in persons with mild to moderate dementia due to Alzheimer's disease (AD) i

Updated on:March 07,2024 20

Structural analysis of relevant drug targets for Alzheimer's disease

by Bentham Science PublishersAlzheimer's Disease (AD) is classified as a neurodegenerative non-curable disease that affects millions worldwide. Current drugs have side effects that are significant

Updated on: March 07,2024 15

Structural analysis of relevant drug targets for Alzheimer's disease

by Bentham Science PublishersAlzheimer's Disease (AD) is classified as a neurodegenerative non-curable disease that affects millions worldwide. Current drugs have side effects that are significant

Updated on:March 07,2024 15

An anti-apoE4 specific monoclonal antibody counteracts the pathological effects of apoE4 in vivo

by Bentham Science PublishersThe pathological hallmarks of Alzheimer's disease (AD), viz defective Aβ and tau proteins, have been the center of AD-directed therapeutic studies. Although this appro

Updated on: March 07,2024 20

An anti-apoE4 specific monoclonal antibody counteracts the pathological effects of apoE4 in vivo

by Bentham Science PublishersThe pathological hallmarks of Alzheimer's disease (AD), viz defective Aβ and tau proteins, have been the center of AD-directed therapeutic studies. Although this appro

Updated on:March 07,2024 20

Bill Gates giving $50 million for Alzheimer's research

Microsoft co-founder Bill Gates announced Monday that he is investing $50 million to fund research into treatment for Alzheimer's disease.Gates, in an entry on his blog, said he was making the inv

Updated on: March 07,2024 19

Bill Gates giving $50 million for Alzheimer's research

Microsoft co-founder Bill Gates announced Monday that he is investing $50 million to fund research into treatment for Alzheimer's disease.Gates, in an entry on his blog, said he was making the inv

Updated on:March 07,2024 19

Occupational complexity linked to better cognitive performance after damage to the brain's white matter

by Alzheimer's Research UKResearchers in the US have presented findings indicating that individuals who have a history of complex occupations, involving work with other people, are better abl

Updated on: March 07,2024 19

Occupational complexity linked to better cognitive performance after damage to the brain's white matter

by Alzheimer's Research UKResearchers in the US have presented findings indicating that individuals who have a history of complex occupations, involving work with other people, are better abl

Updated on:March 07,2024 19

Living with the risk of Alzheimer's disease

by University of CologneWhat are the expectations of persons who decide to have their risk of Alzheimer's Disease tested? What should doctors pay attention to when ascertaining individual ris

Updated on: March 07,2024 12

Living with the risk of Alzheimer's disease

by University of CologneWhat are the expectations of persons who decide to have their risk of Alzheimer's Disease tested? What should doctors pay attention to when ascertaining individual ris

Updated on:March 07,2024 12

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Updated on: March 07,2024 15

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Updated on:March 07,2024 15

A spherical brain mapping of MR images for the detection of Alzheimer's disease

by Bentham Science PublishersDiagnosis, treatment and care of dementia is one of the major concerns in neurology research and associated healthcare programs. Dementia affects older age groups with a g

Updated on: March 07,2024 20

A spherical brain mapping of MR images for the detection of Alzheimer's disease

by Bentham Science PublishersDiagnosis, treatment and care of dementia is one of the major concerns in neurology research and associated healthcare programs. Dementia affects older age groups with a g

Updated on:March 07,2024 20